Facility
Novo Nordisk - Clayton, North Carolina USA
Operated by Novo Nordisk →US
Oral semaglutide API (Rybelsus); majority of oral tablet semaglutide manufactured here; $4B+ expansion for GLP-1 production
0
Inputs produced
0
Goods downstream
0
Incidents on record
0
Stories